News / Events

COMMERCIALIZATION OF DIGITAL THERAPEUTICS

ADVANCING THE COMMERCIALISATION OF DIGITAL MEDICINES

Join EVERSANA at a number of events as we work to advance the commercialization of digital medicines.

“While advancements in digital medicine take us into a new frontier, these devices can and should be available through existing prescription, distribution and reimbursement infrastructures. The commercial model for digital medicine will be efficient, effective and valuable to payers, providers and most importantly, for the patients and caregivers who need them.” Jim Lang, CEO, EVERSANA


Meet Jim Lang, CEO of EVERSANA at Frontiers Health as he joins a panel on Friday, Nov 15 at 10:15.

Frontiers Health is a global event on digital health innovation with a strong focus on digital therapies, breakthrough technologies, healthcare transformation, investments and ecosystem development.

Frontiers Health

Nov 13-15; Berlin, Germany

View the Agenda

 


EVERSANA – Knowledge Partner at DTX Berlin

 Join the EVERSANA team at the DTX Berlin, taking place on December 3rd & 4th and let’s keep the conversation going around commercializing digital therapeutics.

As a Knowledge Partner, EVERSANA brings a number of solutions to alleviate the barriers facing the adoption of digital therapeutics – from reimbursement strategies, distribution, dispensing, patient engagement and adherence programs.

DTX Berlin

Mövenpick Hotel Berlin

December 3-4

Schedule a meeting with the Digital Therapeutics Commercialization team.


Learn more about the Commercialization of Digital Therapeutics:


Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines.


Advancing the commercialization standard for prescription of digital medicines. [Download Infographic]

 

 


 

EVERSANA™ announces an agreement to acquire Cornerstone Research Group; adds global HEOR capabilities to integrated commercial services platform

CHICAGO  – October 30, 2019  – EVERSANA™, the leading independent provider of commercial services to the life science industry, today announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Headquartered in Burlington, Ontario with an additional location in Sydney, Nova Scotia, Cornerstone Research Group is the leader in Health Economics and Outcomes Research (HEOR) […]

EVERSANA Sponsors CBI’s Gross-to-Net Summit

Improve the accuracy of your forecasting and eliminate hidden costs CBI’s longstanding Gross-to-Net Summit is built for biotech, pharma and generic drug companies of all sizes and stages. Whether your organization is pre-commercial or managing multiple products with large revenue streams, the GTN models and processes shared at the conference are paramount to success and […]

EVERSANA™ named a Great Place to Work by global workplace authority

CHICAGO – October 28, 2019 – EVERSANA™, the leading independent provider of commercial services to the life science industry, has been certified as a Great Place to Work® by the global authority in workplace culture. EVERSANA ranked in the top 15 percent of more than 6,000 organizations worldwide who have submitted for the coveted certification. […]

EVERSANA™ appoints seasoned oncology veteran Suzanne Greenwood to commercial leadership team

Chicago– October 24, 2019 – EVERSANATM, the leading independent provider of global commercial services to the life science industry, today appointed oncology veteran Suzanne Greenwood, RN, BSN, to Senior Vice President, Commercial Solutions. Greenwood joins EVERSANA after more than three decades at leading clinical and pharmaceutical manufacturers, distributors, and technology companies, including Bristol-Myers Squibb, McKesson, […]

EVERSANA participates at DIA Medical Information and Communications Conference

Meet EVERSANA at DIA, November 20-21 EVERSANA is a proud sponsor of the 13th annual DIA Medical Information and Communications Conference. The conference, held in Lisbon, Portugal, brings together medical communication professionals around an agenda focused on patient communications, developing medical information content, shaping the future of medical information, automation, and digital developments. Plan to […]

EVERSANA Proudly Sponsors American Society of Reproductive Medicine

EVERSANA’s Amy Johnson, Donor Tissue Services, will be on-site at the American Society for Reproductive Medicine Scientific Congress and Expo in Philadelphia, PA, October 14 and 15. More than 9,300 professionals from 94 countries will attend this conference featuring top experts in reproductive medicine sharing the latest research and education in reproductive care. Talk with […]

EVERSANA™ expands global channel management capabilities with new 260,000 square foot distribution center

CHICAGO – October 10, 2019 – EVERSANA,™ the leading independent provider of global, commercial services to the life science industry, today announced the expansion of its channel management and 3PL (third party logistics) operation with the addition of a new 260,000 square foot Verified-Accredited Wholesale Distributor (VAWD) certified distribution center in Memphis, Tennessee. The new […]

EVERSANA to participate at ISPOR Copenhagen

Analyze, Deliver, Measure and Communicate Value at Every Stage of the Product Lifecycle. Meet us at ISPOR Copenhagen, November 2-6, 2019 Booth # C3-057 EVERSANA proudly announces our participation at ISPOR Copenhagen, taking place from November 2-6. ISPOR is the leading global conference for Health Economics and Outcomes Research. This year’s conference theme – Digital […]

EVERSANA Sponsors the IntegriChain Access Insights Conference

Please join the EVERSANA team in Atlanta GA, as we discuss challenges that access teams face today and looking into the future on topics such as: Rationalizing gross-to-net Speeding time to therapy Improving patient adherence Optimizing product distribution, market access, and patient access On Tuesday, October 21 at 2:30 pm EST, Tom Doyle, SVP of […]